[go: up one dir, main page]

NO20080890L - Sammensetninger for a redusere forekomsten av medikamentindusert arytmi - Google Patents

Sammensetninger for a redusere forekomsten av medikamentindusert arytmi

Info

Publication number
NO20080890L
NO20080890L NO20080890A NO20080890A NO20080890L NO 20080890 L NO20080890 L NO 20080890L NO 20080890 A NO20080890 A NO 20080890A NO 20080890 A NO20080890 A NO 20080890A NO 20080890 L NO20080890 L NO 20080890L
Authority
NO
Norway
Prior art keywords
drug
compositions
methods
incidence
reduce
Prior art date
Application number
NO20080890A
Other languages
English (en)
Norwegian (no)
Inventor
Ii Joseph Michael Sprafka
Jose M Goulart-Brum
Original Assignee
Procter & Gamble
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Procter & Gamble filed Critical Procter & Gamble
Publication of NO20080890L publication Critical patent/NO20080890L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/496—Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene or sparfloxacin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/365—Lactones
    • A61K31/366—Lactones having six-membered rings, e.g. delta-lactones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/401—Proline; Derivatives thereof, e.g. captopril
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/60—Salicylic acid; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/60—Salicylic acid; Derivatives thereof
    • A61K31/612—Salicylic acid; Derivatives thereof having the hydroxy group in position 2 esterified, e.g. salicylsulfuric acid
    • A61K31/616—Salicylic acid; Derivatives thereof having the hydroxy group in position 2 esterified, e.g. salicylsulfuric acid by carboxylic acids, e.g. acetylsalicylic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/716—Glucans
    • A61K31/724—Cyclodextrins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/06—Antiarrhythmics

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Emergency Medicine (AREA)
  • Biomedical Technology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Toxicology (AREA)
  • Cardiology (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
NO20080890A 2005-07-22 2008-02-21 Sammensetninger for a redusere forekomsten av medikamentindusert arytmi NO20080890L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US70155505P 2005-07-22 2005-07-22
PCT/IB2006/052496 WO2007010498A2 (fr) 2005-07-22 2006-07-20 Compositions permettant de reduire l'incidence d'une arythmie d'origine medicamenteuse

Publications (1)

Publication Number Publication Date
NO20080890L true NO20080890L (no) 2008-03-03

Family

ID=37547445

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20080890A NO20080890L (no) 2005-07-22 2008-02-21 Sammensetninger for a redusere forekomsten av medikamentindusert arytmi

Country Status (19)

Country Link
US (2) US8183284B2 (fr)
EP (1) EP1906966A2 (fr)
JP (1) JP4880685B2 (fr)
KR (1) KR20080017489A (fr)
CN (1) CN101227908A (fr)
AR (1) AR055091A1 (fr)
AU (1) AU2006271230A1 (fr)
BR (1) BRPI0613670A2 (fr)
CA (1) CA2615975C (fr)
IL (1) IL188831A0 (fr)
MA (1) MA29622B1 (fr)
MX (1) MX2008001063A (fr)
NO (1) NO20080890L (fr)
PE (1) PE20070369A1 (fr)
RU (1) RU2376994C2 (fr)
SM (1) SMP200800012B (fr)
TW (1) TW200744613A (fr)
WO (1) WO2007010498A2 (fr)
ZA (1) ZA200800564B (fr)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN105534976A (zh) * 2016-01-14 2016-05-04 山东大学 2-(2,2-二苯基环丙基)-4,5-二氢-1h-咪唑在制备抗神经退化性疾病药物中的应用
CA3024989C (fr) 2016-05-19 2024-02-27 Tabula Rasa Healthcare, Inc. Methodes de traitement ayant une toxicite medicamenteuse reduite et methodes d'identification de la nuisibilite de medicaments prescrits pour un patient
JPWO2018124236A1 (ja) * 2016-12-27 2019-11-14 国立大学法人大阪大学 難治性心疾患治療用医薬組成物
WO2020091512A1 (fr) * 2018-11-02 2020-05-07 (주)셀트리온 Composition pharmaceutique destinée à être utilisée dans le traitement de la cardiomyopathie hypertrophique
EP4003317B1 (fr) * 2019-07-29 2023-09-20 Matthias Rath Ascorbate dans la prévention de la calcification vasculaire induite par la statine

Family Cites Families (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB742544A (en) 1952-02-23 1955-12-30 Kodak Ltd Enteric products
FR2833M (fr) 1962-06-12 1964-10-05 I N I C O Ind Nuclear Invest C
GB1142757A (en) 1967-01-26 1969-02-12 Carter Wallace Therapeutic compositions
GB1269181A (en) 1969-03-24 1972-04-06 Monsanto Co Effervescent compositions
US3887700A (en) * 1969-11-28 1975-06-03 Aspro Nicholas Ltd Analgesic formulations
BE759520A (fr) * 1969-11-28 1971-04-30 Aspro Nicholas Ltd Compositions d'aspirine
JPS58126879A (ja) 1982-01-25 1983-07-28 Nippon Chemiphar Co Ltd 光学活性なピペラジン誘導体ならびに心筋梗塞の予防および治療剤
US4783443A (en) 1986-03-03 1988-11-08 The University Of Chicago Amino acyl cephalosporin derivatives
WO1990009185A1 (fr) 1989-02-16 1990-08-23 Angio-Medical Corp. Composition et procede de traitement d'ulceres gastriques et duodenaux, ainsi que d'erosions muqueuses
GB9104854D0 (en) 1991-03-07 1991-04-17 Reckitt & Colmann Prod Ltd Sustained release compositions
JP3228347B2 (ja) * 1991-06-25 2001-11-12 三菱化学株式会社 シクロプロペノン誘導体
ES2124281T3 (es) * 1992-12-25 1999-02-01 Mitsubishi Chem Corp Derivados de alfa-aminocetonas.
US6316487B1 (en) * 1993-06-16 2001-11-13 Aryx Therapeutics Compounds for treatment of cardiac arrhythmia synthesis, and methods of use
WO1996032942A1 (fr) * 1995-04-19 1996-10-24 Lipoprotein Technologies, Inc. Compositions, trousses et procedes d'administration d'antilipemiques et medicaments contre l'agregation plaquettaire
TWI238064B (en) * 1995-06-20 2005-08-21 Takeda Chemical Industries Ltd A pharmaceutical composition for prophylaxis and treatment of diabetes
WO1998019649A2 (fr) * 1996-11-05 1998-05-14 The Children's Medical Center Corporation Methodes et compositions visant a l'inhibition de l'angiogenese
US6245797B1 (en) * 1997-10-22 2001-06-12 Merck & Co., Inc. Combination therapy for reducing the risks associated with cardio-and-cerebrovascular disease
DE60018704T2 (de) 1999-01-08 2006-05-04 Bacaner, Marvin B., Minneapolis Bretyliumhaltige zusammensetzungen und kits und deren verwendung zur vorbeugung und behandlung cardiovaskulärer erkrankungen
US6884792B2 (en) * 1999-01-08 2005-04-26 Marvin B. Bacaner Bretylium compositions and kits and their use in preventing and treating cardiovascular conditions
WO2003086415A1 (fr) 2002-04-05 2003-10-23 Merck & Co., Inc. Procede d'inhibition de resorption osseuse a l'aide d'une formulation a base d'alendronate et de vitamine d
FR2838057B1 (fr) * 2002-04-05 2005-07-08 Servier Lab Nouvelle association d'un antithrombotique et d'aspirine
CA2483099A1 (fr) * 2002-05-03 2003-11-13 Hexal Ag Formulation pharmaceutique stable contenant une statine combinee avec un inhibiteur de l'ace
JP2006509722A (ja) * 2002-07-03 2006-03-23 エスペリオン セラピューティクス，インコーポレイテッド 脂質代謝異常を治療するためのパンテチン含有組成物
US20050142129A1 (en) * 2002-10-15 2005-06-30 Mangano Dennis T. Methods of preventing morbidity and mortality by perioperative administration of a blood clotting inhibitor
US7674820B2 (en) * 2003-08-07 2010-03-09 Cardiome Pharma Corp. Ion channel modulating activity I
PE20050438A1 (es) * 2003-10-20 2005-06-14 Esperion Therapeutics Inc Formulas farmaceuticas, metodos y regimenes de dosificacion para el tratamiento y la prevencion de sindromes coronarios agudos

Also Published As

Publication number Publication date
EP1906966A2 (fr) 2008-04-09
US20120178724A1 (en) 2012-07-12
MA29622B1 (fr) 2008-07-01
RU2376994C2 (ru) 2009-12-27
AU2006271230A1 (en) 2007-01-25
SMAP200800012A (it) 2008-02-27
MX2008001063A (es) 2008-03-19
AR055091A1 (es) 2007-08-08
WO2007010498A3 (fr) 2007-05-31
JP4880685B2 (ja) 2012-02-22
IL188831A0 (en) 2008-08-07
US8183284B2 (en) 2012-05-22
RU2007148908A (ru) 2009-08-27
CA2615975A1 (fr) 2007-01-25
WO2007010498A2 (fr) 2007-01-25
CA2615975C (fr) 2012-11-27
TW200744613A (en) 2007-12-16
BRPI0613670A2 (pt) 2011-01-25
JP2009502773A (ja) 2009-01-29
SMP200800012B (it) 2008-02-27
US20070021395A1 (en) 2007-01-25
ZA200800564B (en) 2008-12-31
CN101227908A (zh) 2008-07-23
PE20070369A1 (es) 2007-05-16
KR20080017489A (ko) 2008-02-26

Similar Documents

Publication Publication Date Title
NO20081843L (no) Farmasoytisk sammensetning for forbedret kognitiv funksjon
BRPI0415121A (pt) material particulado, forma de dosagem sólida, método para fabricar a mesma, e, uso de um material particulado ou de uma forma de dosagem sólida
NO20082673L (no) Nye 2-amino-imidazol-4-on forbindelser og deres anvendelse i fremstilling av et medikament som skal brukes til behandling av kognitiv svekkelse, Alzheimers sykdom, neurodegenerasjon og demens
CL2004001174A1 (es) Composicion farmaceutica que comprende: 1-(4-fluorofenil)-3(r)-[3-(4-fluorofenil)-3(s)-hidroxipropil]-4(s)-(4-hidroxifenil)-2-acetidinona (ezetimiba) y excipientes; y su uso en el tratamiento y/o prevencion de aterosclerosis, hipercolesterolemia, dia
NO20064347L (no) Substituerte 1,2,3,4-tetrahydroisokinolinderivater
NO20052739L (no) CCR5-antagonister som medikamenter
BR0215184A (pt) composições farmacêuticas de derivados de taxano oralmente ativos tendo biodisponibilidade aumentada
NO20025601D0 (no) Arylmetylaminderivater for anvendelse som tryptaseinhibitorer
NO20082088L (no) Azetidiner som MEK-inhibitorer for behandling av proliferative sykdommer
BRPI0416752A (pt) composição farmacêutica, uso de um ou mais compostos, método para a prevenção ou tratamento de distúrbios, compostos, e, processo para a preparação de uma composição farmacêutica
CO5251419A1 (es) Composiciones nanoparticuladas de eplerenona
DE602004007808D1 (de) Neue gamma secretase inhibitoren
TW200615266A (en) Organic compounds
NO20082643L (no) Isokinolinaminopyrazolderivater, deres fremstilling og anvendelse som farmasoytiske midler for behandling av kreft
NO20063449L (no) Substituerte heterocykler og deres anvendelse
ECSP088430A (es) Diarilurea para el tratamiento de hipertensión pulmonar
CL2007000789A1 (es) Compuestos derivados de malonamida, inhibidores de la gamma-secretasa; proceso de preparacion; composicion farmaceutica; y su uso en el tratamiento de la enfermedad de alzheimer.
GB0222514D0 (en) Organic compounds
NO20080890L (no) Sammensetninger for a redusere forekomsten av medikamentindusert arytmi
DE60140871D1 (de) Arylmethylamin-derivate zur verwendung als inhibitoren von tryptase
EA200701113A1 (ru) Макролиды
NO20076405L (no) Anvendelse av 24-nor-UDCA
BR0315462A (pt) Composto, composição farmacêutica, uso de um composto, método para o tratamento de um sujeito que sofre de uma condição patológica ou de doença susceptìvel de alìvio por antagonismo de receptores de ltd4 e produto de combinação
DE602006020295D1 (de) Azabenzimidalzolderivate, ihre herstellung und ihre verwendung als antikrebsmittel
ATE433450T1 (de) Substituierte 1,4,8-triazaspiro 4.5 decan-2-on- verbindungen

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application